Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Corium Intl (CORI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Moving Average Crossover Alert: Corium International, Inc. (CORI)

Moving Average Crossover Alert: Corium International, Inc. (CORI)

CORI : 8.43 (-0.94%)
Corium International, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Corium International, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on May 14, 2018 at 5:00 PM Eastern Time.

CORI : 8.43 (-0.94%)
Corium Reports Second Quarter Fiscal 2018 Financial Results and Corporate Highlights

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited...

CORI : 8.43 (-0.94%)
Corium to Report Second Quarter Fiscal 2018 Financial Results on Monday, May 14, 2018

Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the second quarter ended March 31, 2018 on Monday, May 14, 2018 after the close of the U.S. financial...

CORI : 8.43 (-0.94%)
Why the Earnings Streak Will Continue for Corium International (CORI)

Corium International (CORI) is in a good position to beat earnings at its next report as it has a favorable Zacks Rank and positive Earnings ESP.

CORI : 8.43 (-0.94%)
Edible Electronic Circuits Could be a Medical Revolution in the Waiting

FN Media Group Presents USA News Group News Commentary

AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
BSX : 30.31 (-0.30%)
SUPN : 57.25 (+2.88%)
BDX : 223.73 (-0.83%)
BAX : 72.53 (+0.17%)
CORI : 8.43 (-0.94%)
AXSM : 3.35 (+3.08%)
CymaBay Therapeutics (CBAY) in Focus: Stock Moves 11.4% Higher

CymaBay Therapeutics (CBAY) was a big mover last session, as the company saw its shares rise more than 11% on the day.

CBAY : 11.36 (-7.27%)
CORI : 8.43 (-0.94%)
Corium to Present at the 17th Annual Needham Healthcare Conference

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 8.43 (-0.94%)
Drug Makers use Nanotechnology to Improve Delivery and Dosing

LOS ANGELES, March 16, 2018 /PRNewswire/ --

ABT : 62.37 (-0.22%)
AQS.VN : 0.250 (-1.96%)
SUPN : 57.25 (+2.88%)
CORI : 8.43 (-0.94%)
MDT : 86.30 (-0.79%)
ZYNE : 10.14 (+0.60%)
Corium Prices Offering of $100 Million of 5% Convertible Senior Notes

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the...

CORI : 8.43 (-0.94%)
Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 8.43 (-0.94%)
Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited...

CORI : 8.43 (-0.94%)
Corium International, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Corium International, Inc. (NASDAQ: CORI) will be discussing their earnings results in their Q1 Earnings Call to be held on February 8, 2018 at 5:00 PM Eastern...

CORI : 8.43 (-0.94%)
Corium to Present at Upcoming Healthcare Investor Conferences

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 8.43 (-0.94%)
Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018

Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the first quarter ended December 31, 2017 on February 8, 2018 after the close of the U.S. financial markets....

CORI : 8.43 (-0.94%)
Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla(R) (AG200-15) for the Prevention of Pregnancy

Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) in response to the New Drug...

AGRX : 0.59 (-4.07%)
CORI : 8.43 (-0.94%)
Corium to Join NASDAQ Biotechnology Index

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 8.43 (-0.94%)
Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017

Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the fourth quarter and fiscal year ended September 30, 2017 on Thursday, November 16, 2017 after the close...

CORI : 8.43 (-0.94%)
Corium to Present at Upcoming Healthcare Conferences

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 8.43 (-0.94%)
Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole

VANCOUVER, BC--(Marketwired - August 24, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing,...

AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
CORI : 8.43 (-0.94%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU -0.23 , ABMD -0.18 , AAXN +0.93 , NSP -0.05 , ERI +0.50
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures ended the Friday session with gains of 1 to 2 3/4 cents in the front months. July was up 3 1/2 cents on the week. CFTC data showed speculators adding 8,298 contracts to their net long position in corn futures and options to 199,970 in th...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar